Back to Results

Ventas Inc (VTR)

Featured in Overvalued Stocks

Ventas, Inc. is a health care real estate investment trust listed on the New York Stock Exchange under the ticker VTR. The company focuses on properties that serve an aging population and operates a portfolio of about 1,400 assets across North America and the United Kingdom. Its holdings include more than 850 senior housing communities, as well as outpatient medical buildings, research centers, and other healthcare facilities. Ventas says its growth approach is supported by operating expertise, data-driven insights from its Ventas OI platform, long-standing relationships, and a strong financial position. Incorporated in Delaware in 1983, the company emphasizes environments intended to support residents and patients in longer, healthier lives.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-VTR
$73.21
-24.6% Downside
Overvalued
$97.82
0.7% Upside
Fair
Great
—
—
2.08
2.2%
July 29, 2026
181.1x
3.6x
7.8x
47.125 B
59.373 B
21.1%
99.5%
1.8
342.2%
515.4%
Send a message
Valuation • Fair Value

Ventas Inc (NYSE-VTR) Fair Value by Valuation Model

Compare the primary fair value estimate for Ventas Inc (NYSE-VTR) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$73.21

Estimated downside of 24.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$5.94

Classic Ben Graham valuation formula reference.

DDM Fair Value

$46.45

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$86.60

Comparable-company valuation reference.

Analyst Price Target

$97.82

Analysts imply upside of 0.7%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Ventas Inc (NYSE-VTR) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Ventas Inc (NYSE-VTR)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

6.113 B

Current operating scale indicator.

Revenue Forecast

6.896 B

Forward revenue estimate.

EBITDA

2.288 B

Current operating profitability reference.

EBITDA Forecast

2.527 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ventas Inc (NYSE-VTR) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ventas Inc (NYSE-VTR)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.55

No elevated caution signal from this screen.

Altman Z-Score

1.8

Intermediate risk zone.

FCF / Net Income

515.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ventas Inc (NYSE-VTR). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ventas Inc (NYSE-VTR)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

2.2%

Income yield reference.

Upcoming Dividend

2.08

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

342.2%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Ventas Inc (NYSE-VTR), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ventas Inc (NYSE-VTR) Stock Forecast & Technical Outlook

Review Ventas Inc (NYSE-VTR) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Ventas Inc (NYSE-VTR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Ventas Inc (NYSE-VTR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Ventas Inc (NYSE-VTR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Ventas Inc (NYSE-VTR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Ventas Inc (NYSE-VTR) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ventas Inc (NYSE-VTR)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Ventas Inc (NYSE-VTR) has a Strong Buy consensus, with 14 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 14
Hold 5
Sell 0
FAQ • Fast Investor Answers

Ventas Inc (NYSE-VTR) Stock FAQ

Quick answers about Ventas Inc (NYSE-VTR) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$73.21
Estimated downside 24.6%
Valuation Rating
Overvalued
Estimated downside of 24.6%
Analyst Target
$97.82
Implied upside 0.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Ventas Inc (NYSE-VTR) is $73.21. This implies an estimated downside of 24.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 24.6% versus the current market price.

The available analyst price target for Ventas Inc (NYSE-VTR) is $97.82. The analyst target implies estimated upside of 0.7%.

The current financial health read for Ventas Inc (NYSE-VTR) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ventas Inc (NYSE-VTR) is July 29, 2026.

Based on the current data, dividend yield is 2.2%, upcoming dividend amount is 2.08.

The current P/E ratio listed for Ventas Inc (NYSE-VTR) is 181.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ventas Inc is 47.125 B.

The current enterprise value listed for Ventas Inc is 59.373 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ventas Inc is NYSE-VTR, and the stock is listed on NYSE.

Ventas Inc (NYSE-VTR) is listed on NYSE.

The current debt-to-total-capital ratio listed for Ventas Inc is 21.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ventas Inc is 99.5%. Free float helps investors understand how much of the share base is available for public trading.

Similar Health Care REITs Stocks on NYSE View more

Welltower Inc (WELL) Welltower Inc (WELL)
Healthpeak Properties Inc (DOC) Healthpeak Properties Inc (DOC)
Omega Healthcare Investors Inc (OHI) Omega Healthcare Investors Inc (OHI)
American Healthcare REIT Inc (AHR) American Healthcare REIT Inc (AHR)
Caretrust Inc (CTRE) Caretrust Inc (CTRE)
Alexandria Real Estate Equities Inc (ARE) Alexandria Real Estate Equities Inc (ARE)
Healthcare Realty Trust Incorporated (HR) Healthcare Realty Trust Incorporated (HR)
National Health Investors Inc (NHI) National Health Investors Inc (NHI)
Medical Properties Trust Inc (MPT) Medical Properties Trust Inc (MPT)
LTC Properties Inc (LTC) LTC Properties Inc (LTC)
Strawberry Fields Reit Inc (STRW) Strawberry Fields Reit Inc (STRW)
Universal Health Realty Income Trust (UHT) Universal Health Realty Income Trust (UHT)
Chiron Real Estate Inc (XRN) Chiron Real Estate Inc (XRN)
Chiron Real Estate Inc Preferred Series A (XRN_pa) Chiron Real Estate Inc Preferred Series A (XRN_pa)
Chiron Real Estate Inc Preferred Series B (XRN_pb) Chiron Real Estate Inc Preferred Series B (XRN_pb)
Community Healthcare Trust Inc (CHCT) Community Healthcare Trust Inc (CHCT)